Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 18108

1.

Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infection.

Forrest C, Hislop AD, Rickinson AB, Zuo J.

PLoS Pathog. 2018 Sep 24;14(9):e1007110. doi: 10.1371/journal.ppat.1007110. [Epub ahead of print]

PMID:
30248160
2.

Characterization of eomesodermin and T-bet expression by allostimulated CD8+ T cells of healthy volunteers and kidney transplant patients in relation to graft outcome.

Perez-Gutierrez A, Metes DM, Lu L, Hariharan S, Thomson AW, Ezzelarab MB.

Clin Exp Immunol. 2018 Sep 23. doi: 10.1111/cei.13162. [Epub ahead of print]

PMID:
30246373
3.

Folliculotropic CD8+ mycosis fungoides associated with diffuse mucosal involvement.

de Masson A, Frumholtz L, Battistella M, Vignon-Pennamen MD, de Belilovsky C, Husson C, Ram-Wolff C, Frances C, Bagot M, Cordoliani F.

JAAD Case Rep. 2018 Sep 14;4(8):777-779. doi: 10.1016/j.jdcr.2018.04.005. eCollection 2018 Sep. No abstract available.

PMID:
30246124
4.

An Ad/MVA vectored Theileria parva antigen induces schizont-specific CD8+ central memory T cells and confers partial protection against a lethal challenge.

Svitek N, Saya R, Awino E, Munyao S, Muriuki R, Njoroge T, Pellé R, Ndiwa N, Poole J, Gilbert S, Nene V, Steinaa L.

NPJ Vaccines. 2018 Sep 11;3:35. doi: 10.1038/s41541-018-0073-5. eCollection 2018.

PMID:
30245859
5.

Opinion: Virtual memory CD8 T cells and lymphopenia-induced memory CD8 T cells represent a single subset: homeostatic memory T cells.

Pribikova M, Moudra A, Stepanek O.

Immunol Lett. 2018 Sep 20. pii: S0165-2478(18)30251-7. doi: 10.1016/j.imlet.2018.09.003. [Epub ahead of print] Review.

PMID:
30243945
6.

The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response.

Dikhit MR, Das S, Mahantesh V, Kumar A, Singh AK, Dehury B, Rout AK, Ali V, Sahoo GC, Topno RK, Pandey K, Das VNR, Bimal S, Das P.

Sci Rep. 2018 Sep 21;8(1):14175. doi: 10.1038/s41598-018-32040-x.

7.

Stabilization of Foxp3 by Targeting JAK2 Enhances Efficacy of CD8 Induced Regulatory T Cells in the Prevention of Graft-versus-Host Disease.

Iamsawat S, Daenthanasanmak A, Voss JH, Nguyen H, Bastian D, Liu C, Yu XZ.

J Immunol. 2018 Sep 21. pii: ji1800793. doi: 10.4049/jimmunol.1800793. [Epub ahead of print]

PMID:
30242073
8.

Development of a BiTE®-mediated CD8+ cytotoxic T-lymphocyte activity assay to assess immunomodulatory potential of drug candidates in Cynomolgus macaque.

Frank B, Wei YL, Kim KH, Guerrero A, Lebrec H, Balazs M, Wang X.

J Immunotoxicol. 2018 Dec;15(1):119-125. doi: 10.1080/1547691X.2018.1486342.

PMID:
30241454
9.

Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy.

Tsiatas M, Kalogeras KT, Manousou K, Wirtz RM, Gogas H, Veltrup E, Zagouri F, Lazaridis G, Koutras A, Christodoulou C, Pentheroudakis G, Petraki C, Bafaloukos D, Pectasides D, Kosmidis P, Samantas E, Karanikiotis C, Papakostas P, Dimopoulos MA, Fountzilas G.

Cancer Med. 2018 Sep 21. doi: 10.1002/cam4.1730. [Epub ahead of print]

10.

Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8+ T cells.

Desgrandchamps F, LeMaoult J, Goujon A, Riviere A, Rivero-Juarez A, Djouadou M, de Gouvello A, Dumont C, Wu CL, Culine S, Verine J, Rouas-Freiss N, Hennequin C, Masson-Lecomte A, Carosella ED.

Oncotarget. 2018 Sep 4;9(69):33160-33169. doi: 10.18632/oncotarget.26036. eCollection 2018 Sep 4.

11.
12.

Early CD8+-recovery independently predicts low probability of disease relapse but also associates with severe GVHD after allogeneic HSCT.

Ranti J, Kurki S, Salmenniemi U, Putkonen M, Salomäki S, Itälä-Remes M.

PLoS One. 2018 Sep 20;13(9):e0204136. doi: 10.1371/journal.pone.0204136. eCollection 2018.

13.

Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunity.

Pilipow K, Scamardella E, Puccio S, Gautam S, De Paoli F, Mazza EM, De Simone G, Polletti S, Buccilli M, Zanon V, Di Lucia P, Iannacone M, Gattinoni L, Lugli E.

JCI Insight. 2018 Sep 20;3(18). pii: 122299. doi: 10.1172/jci.insight.122299. [Epub ahead of print]

14.

A Paradigmatic Interplay between Human Cytomegalovirus and Host Immune System: Possible Involvement of Viral Antigen-Driven CD8+ T Cell Responses in Systemic Sclerosis.

Arcangeletti MC, Maccari C, Vescovini R, Volpi R, Giuggioli D, Sighinolfi G, De Conto F, Chezzi C, Calderaro A, Ferri C.

Viruses. 2018 Sep 18;10(9). pii: E508. doi: 10.3390/v10090508.

15.

PD-L1 expression and CD8-positive T cells are associated with favorable survival in HER2-positive invasive breast cancer.

Hou Y, Nitta H, Wei L, Banks PM, Lustberg M, Wesolowski R, Ramaswamy B, Parwani AV, Li Z.

Breast J. 2018 Sep 19. doi: 10.1111/tbj.13112. [Epub ahead of print]

PMID:
30230111
16.

Reduced CD8+ T cells infiltration can be associated to a malignant transformation in potentially malignant oral epithelial lesions.

Chaves ALF, Silva AG, Maia FM, Lopes GFM, de Paulo LFB, Muniz LV, Dos Santos HB, Soares JMA, Souza AA, de Oliveira Barbosa LA, Loyola AM, Murta EFC, Michelin MA, de Azambuja Ribeiro RIM.

Clin Oral Investig. 2018 Sep 19. doi: 10.1007/s00784-018-2622-8. [Epub ahead of print]

PMID:
30229300
17.

β-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress.

Qiao G, Bucsek MJ, Winder NM, Chen M, Giridharan T, Olejniczak SH, Hylander BL, Repasky EA.

Cancer Immunol Immunother. 2018 Sep 18. doi: 10.1007/s00262-018-2243-8. [Epub ahead of print]

PMID:
30229289
18.

Clinically-Relevant Rapamycin Treatment Regimens Enhance CD8+ Effector Memory T Cell Function In The Skin and Allow their Infiltration into Cutaneous Squamous Cell Carcinoma.

Jung JW, Veitch M, Bridge JA, Overgaard NH, Cruz JL, Linedale R, Franklin ME, Saunders NA, Simpson F, Frazer IH, Steptoe RJ, Wells JW.

Oncoimmunology. 2018 Jul 30;7(9):e1479627. doi: 10.1080/2162402X.2018.1479627. eCollection 2018.

PMID:
30228949
19.

Stromal cell PD-L1 inhibits CD8+ T-cell antitumor immune responses and promotes colon cancer.

O'Malley G, Treacy O, Lynch K, Naicker SD, Leonard NA, Lohan P, Dunne PD, Ritter T, Egan LJ, Ryan AE.

Cancer Immunol Res. 2018 Sep 18. pii: canimm.0443.2017. doi: 10.1158/2326-6066.CIR-17-0443. [Epub ahead of print]

PMID:
30228206
20.

Soluble LAG3 acts as a potential prognostic marker of gastric cancer and its positive correlation with CD8+T cell frequency and secretion of IL-12 and INF-γ in peripheral blood.

Li N, Jilisihan B, Wang W, Tang Y, Keyoumu S.

Cancer Biomark. 2018 Sep 7. doi: 10.3233/CBM-181278. [Epub ahead of print]

PMID:
30223387

Supplemental Content

Support Center